The Rise and Fall of " Biopsy and Radiate": A History of Surgical Nihilism in Glioma Treatment

Neurosurgery Clinics of North America

Volumn 23, Issue 2, 2012, Pages 207-214

  Han, Seunggu J ^a   Sughrue, Michael E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Glioma; Resection; Surgery

Indexed keywords

KI 67 ANTIGEN;

ASTROCYTOMA; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; EPENDYMOMA; GLIOMA; HEMISPHERECTOMY; HUMAN; MENINGIOMA; METASTASIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; TUMOR RECURRENCE; TUMOR REGRESSION;

BRAIN NEOPLASMS; GLIOMA; HUMANS; NEUROSURGICAL PROCEDURES;

EID: 84858604498     PISSN: 10423680     EISSN: 15581349     Source Type: Journal    
DOI: 10.1016/j.nec.2012.02.002     Document Type: Review

References (51)

1. Berger M.S., Deliganis A.V., Dobbins J., et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994, 74(6):1784-1791.
2. Sanai N., Berger M.S. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008, 62(4):753-764. [discussion: 264-6].
3. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996.
4. Yordanova Y.N., Moritz-Gasser S., Duffau H. Awake surgery for WHO Grade II gliomas within " noneloquent" areas in the left dominant hemisphere: toward a " supratotal" resection. J Neurosurg 2011, 115(2):232-239.
5. Laperriere N., Zuraw L., Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002, 64(3):259-273.
6. Berger M.S., Rostomily R.C. Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol 1997, 34(1):85-101.
7. Silbergeld D.L., Chicoine M.R. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 1997, 86(3):525-531.
8. Dandy W. Removal of the right cerebral hemisphere for certain tumors with hemiplegia: preliminary report. JAMA 1928, 90(11):823-825.
9. Bell E., Karnosh L. Cerebral hemispherectomy: report of a case ten years after operation. J Neurosurg 1949, 6(4):285-293.
10. Wilson P.J., Ashley D.J. Meningioma after contralateral hemispherectomy for malignant glioma: case report. J Neurol Neurosurg Psychiatry 1975, 38(5):493-499.
11. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis 1926, JB Lippincott, Philadelphia. P. Bailey (Ed.).
12. Scherer H.J. The forms of growth in gliomas and their practical significance. Brain 1940, 63(1):1-34.
13. Marsh J.S. The necropsy incidence of glioblastoma multiforme; with reference to its age and sex occurrence in a series of four hundred and twenty-three intracranial gliomas verified at autopsy. Bull Los Angel Neuro Soc 1956, 21(1):27-29.
14. Salazar O.M., Rubin P. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1976, 1(7-8):627-637.
15. Burger P.C., Dubois P.J., Schold S.C., et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 1983, 58(2):159-169.
16. Gaspar L.E., Fisher B.J., Macdonald D.R., et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 1992, 24(1):55-57.
17. Wallner K.E., Galicich J.H., Krol G., et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989, 16(6):1405-1409.
18. Kelly P.J., Daumas-Duport C., Kispert D.B., et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987, 66(6):865-874.
19. Pallud J., Varlet P., Devaux B., et al. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 2010, 74(21):1724-1731.
20. Talmadge J.E., Fidler I.J. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 2010, 70(14):5649-5669.
21. Stummer W., Pichlmeier U., Meinel T., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7(5):392-401.
22. Sanai N., Polley M.Y., McDermott M.W., et al. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011, 115(1):3-8.
23. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001, 95(2):190-198.
24. Smith J.S., Chang E.F., Lamborn K.R., et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008, 26(8):1338-1345.
25. Chang E.F., Potts M.B., Keles G.E., et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008, 108(2):227-235.
26. Englot D.J., Berger M.S., Barbaro N.M., et al. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. J Neurosurg 2011, 115(2):240-244.
27. Sughrue M.E., Kaur R., Rutkowski M.J., et al. Extent of resection and the long-term durability of vestibular schwannoma surgery. J Neurosurg 2011, 114(5):1218-1223.
28. Jian B.J., Sughrue M.E., Kaur R., et al. Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection. Neurosurgery 2011, 68(4):874-880. [discussion: 879-80].
29. Sughrue M.E., Kaur R., Rutkowski M.J., et al. A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age. Neurosurgery 2010, 67(6):1646-1653. [discussion: 1653-4].
30. Sughrue M.E., Yang I., Rutkowski M.J., et al. Preservation of facial nerve function after resection of vestibular schwannoma. Br J Neurosurg 2010, 24(6):666-671.
31. Bloch O., Sughrue M.E., Kaur R., et al. Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol 2011, 102(2):281-286.
32. Sughrue M.E., Yang I., Aranda D., et al. Hearing preservation rates after microsurgical resection of vestibular schwannoma. J Clin Neurosci 2010, 17(9):1126-1129.
33. Sughrue M.E., Kaur R., Kane A.J., et al. Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg 2011, 114(2):386-393.
34. Sughrue M.E., Kane A.J., Kaur R., et al. A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg 2011, 114(2):381-385.
35. Sughrue M.E., Kaur R., Kane A.J., et al. The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery. J Clin Neurosci 2010, 17(7):849-852.
36. Sughrue M.E., Yang I., Han S.J., et al. Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma. Neurosurg Focus 2009, 27(6):E4.
37. Yeung A.H., Sughrue M.E., Kane A.J., et al. Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization. Neurosurg Focus 2009, 27(6):E2.
38. Sughrue M.E., Yang I., Aranda D., et al. Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg 2011, 114(2):367-374.
39. Sughrue M.E., Yeung A.H., Rutkowski M.J., et al. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. J Neurosurg 2011, 114(2):359-366.
40. Yang I., Sughrue M.E., Han S.J., et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg 2010, 112(4):851-859.
41. Sughrue M.E., Yang I., Aranda D., et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg 2010, 112(1):163-167.
42. Yang I., Sughrue M.E., Han S.J., et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol 2009, 93(1):41-48.
43. Yang I., Aranda D., Han S.J., et al. Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci 2009, 16(6):742-747.
44. Langevin C.J., Hanasono M.M., Riina H.A., et al. Lateral transzygomatic approach to sphenoid wing meningiomas. Neurosurgery 2010, 67(2 Suppl Operative):377-384.
45. Sindou M., Mazoyer J.F., Fischer G., et al. Experimental bypass for sagittal sinus repair. Preliminary report. J Neurosurg 1976, 44(3):325-330.
46. Liu J.K., Couldwell W.T. Interpositional carotid artery bypass strategies in the surgical management of aneurysms and tumors of the skull base. Neurosurg Focus 2003, 14(3):e2.
47. Sindou M., Hallacq P. Venous reconstruction in surgery of meningiomas invading the sagittal and transverse sinuses. Skull Base Surg 1998, 8(2):57-64.
48. Laws E.R., Taylor W.F., Clifton M.B., et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984, 61(4):665-673.
49. Axtell A.E., Lee M.H., Bristow R.E., et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 2007, 25(4):384-389.
50. Kreth F.W., Warnke P.C., Scheremet R., et al. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 1993, 78(5):762-766.
51. Bernstein M., Hoffman H.J., Halliday W.C., et al. Thalamic tumors in children. Long-term follow-up and treatment guidelines. J Neurosurg 1984, 61(4):649-656.